Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)

SHA:600196 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	75,382	59,749	61,592	86,922	113,862	125,791
Market Cap Growth	39.17%	-2.99%	-29.14%	-23.66%	-9.48%	93.27%
Enterprise Value	109,447	90,784	89,228	110,109	134,998	147,717
Last Close Price	29.84	24.56	24.46	33.95	46.54	51.04
PE Ratio	24.53	21.57	25.82	23.30	24.08	34.34
Forward PE	35.52	21.15	21.49	19.36	20.43	30.68
PS Ratio	1.88	1.46	1.49	1.98	2.92	4.15
PB Ratio	1.25	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	3.40	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	240.66	894.58	-	-	-	-
P/OCF Ratio	16.03	13.35	18.04	20.61	28.92	48.76
PEG Ratio	-	1.02	1.02	1.02	1.02	2.05
EV/Sales Ratio	2.73	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	19.36	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	42.65	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	349.41	1359.25	-	-	-	-
Debt / Equity Ratio	0.61	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.51	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	117.44	539.31	-	-	-	-
Asset Turnover	0.34	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	2.96	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.71	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.95	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.82%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.37%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Capital (ROIC)	1.68%	1.98%	0.84%	2.70%	2.21%	2.50%
Return on Capital Employed (ROCE)	3.10%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	4.31%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.42%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	1.07%	1.30%	1.10%	1.24%	1.20%	0.84%
Payout Ratio	65.25%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	-0.09%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	0.98%	1.28%	-1.29%	-0.50%	1.20%	0.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.